GlassScriptPhysician profile
Ala Mohsen
NPI 1336580133
$10,583.35
in general payments reported to CMS, 2019-2025
35 companies · $1,773 in 2025
The $1,773 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,564 · 2020: $246 · 2021: $1,035 · 2022: $746 · 2023: $2,653 · 2024: $2,567 · 2025: $1,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,962 · Travel and Lodging: $30.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,962.22 |
| Travel and Lodging | $30.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,510.42 | 2019-2025 | Diamondback Coronary, Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Boston Scientific Corporation | $1,228.78 | 2019-2025 | Farapulse, Ekosonic, Eluvia |
| Inari Medical, INC. | $1,204.37 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $1,010.05 | 2019-2025 | Impella |
| Penumbra, INC. | $713.41 | 2023-2025 | Indigo System |
| Shockwave Medical, INC | $692.12 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $485.97 | 2019-2024 | Xarelto |
| Cardiovascular Systems INC. | $431.71 | 2022-2023 | Diamondback Coronary |
| Stryker Corporation | $352.46 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $285.50 | 2022-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $275.95 | 2019-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $247.04 | 2020-2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $238.12 | 2019-2025 | |
| Amgen INC. | $176.68 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $168.07 | 2019-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $164.99 | 2023-2025 | Symphony Catheter, Prodigy Catheter |
| Terumo Medical Corporation | $163.25 | 2020-2023 | Glidesheath Slender |
| Recor Medical INC | $155.33 | 2024 | Paradise Renal Denervation System |
| Angiodynamics, INC. | $137.87 | 2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Chiesi USA, INC. | $132.02 | 2021 | |
| Scpharmaceuticals INC. | $125.74 | 2025 | |
| Surmodics, INC. | $117.06 | 2023 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Baxter Healthcare | $92.46 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.44 | 2023 | Jardiance |
| Bard Peripheral Vascular, INC. | $70.45 | 2023 | Rotarexs 6 F X 135 Cm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.47 | 2024 | Lifevest |
| Merck Sharp & Dohme LLC | $52.85 | 2023-2025 | Verquvo |
| Biosense Webster, INC. | $49.97 | 2025 | Carto 3 |
| Livanova USA, INC. | $32.85 | 2023 | Lifesparc |
| United Therapeutics Corporation | $32.60 | 2019 | |
| Medtronic, INC. | $30.05 | 2025 | Hawkone |
| Actelion Pharmaceuticals US, INC. | $19.50 | 2023 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals International, Plc | $19.43 | 2024 | Arcalyst |
| Ge Healthcare | $16.18 | 2023 | |
| Sanofi-Aventis U.S. LLC | $14.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ala Mohsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.